Fda Continuously Warns of Drug Counterfeiting

Fighting counterfeiting presents a substantial public health problem. The figures most commonly cited by international organizations indicate counterfeiting in an average of 10% globally, although this figure may be higher in other regions and pharmaceutical markets which are not fully aware of the extent of the issue in their region. The pharmaceutical regulations in these areas are not even fully anchored and sometimes victims of fraudulence headed by their own authorities. Counterfeiting is most rampant in regions where regulatory policies and systems of medicines are weakest.